Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel;Behandling med trombocytaggregationshæmmeren clopidogrel ved iskæmisk sygdom

Ugeskrift for Laeger

Volumn 166, Issue 18, 2004, Pages 1659-1662

  Helø, Olav H ^b   Madsen, Jan Kyst ^b   Kastrup, Jens ^a  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; TICLOPIDINE; DRUG DERIVATIVE;

CLINICAL TRIAL; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; SECONDARY PREVENTION; SHORT SURVEY; ST SEGMENT; SYSTEMATIC REVIEW; TREATMENT PLANNING; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG COMBINATION; HEART MUSCLE ISCHEMIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; STENT;

ASPIRIN; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; HUMANS; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; STENTS; TICLOPIDINE;

EID: 2542427463     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Zusman RM, Chesebro JH, Comerota A et al. Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection. Clin Cardiol 1999;22:559-73.
2. Antiplatelet Trialists' Colloboration. Collaborative overview of randomized trials of antiplatelet therapy, 1: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:91-106.
3. Coukell AJ, Markham A. Clopidogrel. Drugs 1997;54:745-50.
4. Lau WC, Lucy A, Watkins PB et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation. Circulation 2003;107:32-7.
5. CAPRIE Steering Commitee. A randomised, blinded, trial of clopidogrel versus Aspirin in patients at risk of ischemic events. Lancet 1996;348: 1329-39.
6. Bhatt DL, Chew DP, Hirsch AT et al. Superiority of clopidogrel versus Aspirin in patients with prior cardiac surgery. Circulation 2001;103:363-8.
7. Bertrand ME, Rupprecht HJ, Urban P et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with Aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-9.
8. Bhatt DL, Bertrand ME, Berger PB et al. Meta-analyses of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002;39:9-14.
9. Steinhubl SR, Berger PB, Mann JT et al. Early and sustained dual oral anti-platelet therapy following percutaneous coronary intervention. JAMA 2002; 288:2411-20.
10. Topol EJ, Moliterno DJ, Herrmann HC et al. Comparison of two platelet glycoprotein Iib/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. New Engl J Med 2001;344:1888-94.
11. Waksman R, Ajani AE, White RL et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma radiation in patients with instent restenosis: Washington radiation for in-stent restenosis trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 2001;103:2332-5.
12. The clopidogrel in unstable angina to prevent recurrent events (CURE) trial investigators. Effects of clopidogrel in addition to Aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
13. Budaj A, Yusuf S, Metha SR et al. Benefit of clopidogrel in patients with acute coronary syndromes without ST-elevation in various risk groups. Circulation 2002;106:1622-6.
14. Metha SR, Yusuf S, Peters RJG et al. Effects of pretreatment with clopidogrel and Aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
15. Otterstad JE, Fox KAA. Clinical implications of Cure and PCI-CURE in patients with the acute coronary syndrome without persistent ST-elevation. Scand Cardiovasc J 2002;36:262-71.
16. Albers GW, Amarenco P. Combination therapy with clopidogrel and Aspirin. Stroke 2001;32:2948-9.
17. Lægemiddelstyrelsen. Kriterier for tilskud til Plavix. Ugeskr Læger 2002; 164:1373-4.